Patients Treated with ARIKAYCE plus macrolide-based background regimen had meaningfully larger improvements in QOL-B respiratory score
Amgen will be prohibited from leveraging its drug portfolio to disadvantage rivals and will be required to seek prior approval before acquiring related products
BioNTech's diverse pipeline includes multiple drugs in Phase I, II, and III clinical trials
The facility has a potential for capacity expansion up to 2 billion tablets/capsules per year
The inspection has concluded successfully on 1st September 2023 without any critical/major observation
Topiramate is the generic version of Supernus Pharmaceuticals’ Trokendi XR
Prasugrel tablets are indicated to reduce the rate of thrombotic CV events
Mankind Pharma's initiative aims to ensure universal access to medicines of international calibre
Subscribe To Our Newsletter & Stay Updated
